|
|
| Efficacy Re: Trump Has Financial Interest In Hydroxychloroquine Maker: NYT (1714773) | |||
 |
|||
| Home > OTChat | |||
|
[ Read Responses | Post a New Response | Return to the Index ] |
|
||
|
Efficacy Re: Trump Has Financial Interest In Hydroxychloroquine Maker: NYT |
|
|
Posted by AlM on Tue Apr 7 13:10:02 2020, in response to Trump Has Financial Interest In Hydroxychloroquine Maker: NYT, posted by JayZeeBMT on Tue Apr 7 08:09:32 2020. Here's an excerpt from the article. It's clear this is not a wonder drug, or NY doctors would have noticed. Hopefully, it will help a bit.New York City’s Health and Hospitals Corporation, which runs its public hospitals, is advising but not requiring doctors to use hydroxychloroquine based on a trial showing a decreased cough and fever with mild side effects in two patients, Dr. Mitchell Katz, who oversees the hospital system, said by email on Monday. Dr. Roy M. Gulick, the chief of infectious diseases at Weill Cornell Medicine, said hydroxychloroquine was given on a case-by-case basis. “We explain the pros and cons and explain that we don’t know if it works or not,” he said. Doctors at Northwell Health and Mount Sinai Health System are using it as well. At the Mount Sinai South Nassau County branch on Long Island, doctors have employed a regimen of hydroxychloroquine and azithromycin “pretty much since day one” with mixed results, said Dr. Adhi Sharma, its chief medical officer. “We’ve been throwing the kitchen sink at these patients,” he said. “I can’t tell whether someone got better on their own or because of the medication.” |
|
(There are no responses to this message.)
|
|